F-star Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2015 to Q3 2022

Taxonomy & unit: us-gaap: USD
Description: The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary: F-star Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2015 to Q3 2022.
F-star Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2022 was -$18.4M, a 70.6% decline year-over-year.
F-star Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2022 was -$44.7M, a 0.4% decline year-over-year.
F-star Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$31.3M, a 22.1% decline from 2020.
F-star Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$25.6M, a 11.3% decline from 2019.
F-star Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2019 was -$23M, a 0.7% decline from 2018.

Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)

Net Income (Loss) Attributable to Parent, Quarterly (USD)

Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2022	-$44.7M	-$18.4M	-$7.62M	-70.6%	Jul 1, 2022	Sep 30, 2022	10-Q	2022-11-10
Q2 2022	-$37.1M	-$19M	-$3.5M	-22.6%	Apr 1, 2022	Jun 30, 2022	10-Q	2022-08-11
Q1 2022	-$33.6M	-$12.1M	-$2.35M	-24.2%	Jan 1, 2022	Mar 31, 2022	10-Q	2022-05-10
Q4 2021	-$31.3M	$4.74M	+$13.3M		Oct 1, 2021	Dec 31, 2021	10-K	2022-03-15
Q3 2021	-$44.6M	-$10.8M	-$7.34M	-213%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-10
Q2 2021	-$37.2M	-$15.5M	-$9.04M	-140%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-11
Q1 2021	-$28.2M	-$9.73M	-$2.58M	-36%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-10
Q4 2020	-$25.6M	-$8.55M	-$2.2M	-34.6%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-15
Q3 2020	-$23.4M	-$3.45M	+$3.46M	+50.1%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020	-$26.9M	-$6.46M	-$1.91M	-41.9%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-13
Q1 2020	-$25M	-$7.16M	-$1.96M	-37.8%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-17
Q4 2019	-$23M	-$6.35M	-$926K	-17.1%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-30
Q3 2019	-$22.1M	-$6.91M	+$1.87M	+21.3%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-03
Q2 2019	-$24M	-$4.56M	-$770K	-20.3%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-10
Q1 2019	-$23.2M	-$5.2M	-$331K	-6.81%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-07
Q4 2018	-$22.9M	-$5.43M	-$3.96M	-271%	Oct 1, 2018	Dec 31, 2018	10-K	2020-02-14
Q3 2018	-$18.9M	-$8.78M	+$2.05M	+18.9%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-07
Q2 2018	-$20.9M	-$3.79M	+$5.1M	+57.4%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-07-31
Q1 2018	-$26M	-$4.86M	+$1.64M	+25.2%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-04-29
Q4 2017	-$27.7M	-$1.46M	+$937K	+39.1%	Oct 1, 2017	Dec 31, 2017	10-K	2019-03-11
Q3 2017	-$28.6M	-$10.8M	-$6.68M	-161%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-10-25
Q2 2017	-$21.9M	-$8.89M	-$4.59M	-107%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-02
Q1 2017	-$17.3M	-$6.5M	+$18K	+0.28%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-04-27
Q4 2016	-$17.4M	-$2.4M	+$1.55M	+39.2%	Oct 1, 2016	Dec 31, 2016	10-K	2018-02-20
Q3 2016	-$18.9M	-$4.15M	-$751K	-22.1%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-10-31
Q2 2016	-$18.2M	-$4.3M	-$2.04M	-90.1%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-07-31
Q1 2016	-$16.1M	-$6.52M	-$4.56M	-233%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-04-28
Q4 2015	-$11.6M	-$3.95M			Oct 1, 2015	Dec 31, 2015	10-K	2017-02-14
Q3 2015		-$3.4M			Jul 1, 2015	Sep 30, 2015	10-Q	2016-10-28
Q2 2015		-$2.26M			Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-01
Q1 2015		-$1.96M			Jan 1, 2015	Mar 31, 2015	10-Q	2016-06-15

* An asterisk sign (*) next to the value indicates that the value is likely invalid.